\documentclass[11pt,twoside]{article}\makeatletter \IfFileExists{xcolor.sty}% {\RequirePackage{xcolor}}% {\RequirePackage{color}} \usepackage{colortbl} \usepackage{wrapfig} \usepackage{ifxetex} \ifxetex \usepackage{fontspec} \usepackage{xunicode} \catcode`⃥=\active \def⃥{\textbackslash} \catcode`❴=\active \def❴{\{} \catcode`❵=\active \def❵{\}} \def\textJapanese{\fontspec{Noto Sans CJK JP}} \def\textChinese{\fontspec{Noto Sans CJK SC}} \def\textKorean{\fontspec{Noto Sans CJK KR}} \setmonofont{DejaVu Sans Mono} \else \IfFileExists{utf8x.def}% {\usepackage[utf8x]{inputenc} \PrerenderUnicode{–} }% {\usepackage[utf8]{inputenc}} \usepackage[english]{babel} \usepackage[T1]{fontenc} \usepackage{float} \usepackage[]{ucs} \uc@dclc{8421}{default}{\textbackslash } \uc@dclc{10100}{default}{\{} \uc@dclc{10101}{default}{\}} \uc@dclc{8491}{default}{\AA{}} \uc@dclc{8239}{default}{\,} \uc@dclc{20154}{default}{ } \uc@dclc{10148}{default}{>} \def\textschwa{\rotatebox{-90}{e}} \def\textJapanese{} \def\textChinese{} \IfFileExists{tipa.sty}{\usepackage{tipa}}{} \fi \def\exampleFont{\ttfamily\small} \DeclareTextSymbol{\textpi}{OML}{25} \usepackage{relsize} \RequirePackage{array} \def\@testpach{\@chclass \ifnum \@lastchclass=6 \@ne \@chnum \@ne \else \ifnum \@lastchclass=7 5 \else \ifnum \@lastchclass=8 \tw@ \else \ifnum \@lastchclass=9 \thr@@ \else \z@ \ifnum \@lastchclass = 10 \else \edef\@nextchar{\expandafter\string\@nextchar}% \@chnum \if \@nextchar c\z@ \else \if \@nextchar l\@ne \else \if \@nextchar r\tw@ \else \z@ \@chclass \if\@nextchar |\@ne \else \if \@nextchar !6 \else \if \@nextchar @7 \else \if \@nextchar (8 \else \if \@nextchar )9 \else 10 \@chnum \if \@nextchar m\thr@@\else \if \@nextchar p4 \else \if \@nextchar b5 \else \z@ \@chclass \z@ \@preamerr \z@ \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi} \gdef\arraybackslash{\let\\=\@arraycr} \def\@textsubscript#1{{\m@th\ensuremath{_{\mbox{\fontsize\sf@size\z@#1}}}}} \def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}} \def\abbr{} \def\corr{} \def\expan{} \def\gap{} \def\orig{} \def\reg{} \def\ref{} \def\sic{} \def\persName{}\def\name{} \def\placeName{} \def\orgName{} \def\textcal#1{{\fontspec{Lucida Calligraphy}#1}} \def\textgothic#1{{\fontspec{Lucida Blackletter}#1}} \def\textlarge#1{{\large #1}} \def\textoverbar#1{\ensuremath{\overline{#1}}} \def\textquoted#1{‘#1’} \def\textsmall#1{{\small #1}} \def\textsubscript#1{\@textsubscript{\selectfont#1}} \def\textxi{\ensuremath{\xi}} \def\titlem{\itshape} \newenvironment{biblfree}{}{\ifvmode\par\fi } \newenvironment{bibl}{}{} \newenvironment{byline}{\vskip6pt\itshape\fontsize{16pt}{18pt}\selectfont}{\par } \newenvironment{citbibl}{}{\ifvmode\par\fi } \newenvironment{docAuthor}{\ifvmode\vskip4pt\fontsize{16pt}{18pt}\selectfont\fi\itshape}{\ifvmode\par\fi } \newenvironment{docDate}{}{\ifvmode\par\fi } \newenvironment{docImprint}{\vskip 6pt}{\ifvmode\par\fi } \newenvironment{docTitle}{\vskip6pt\bfseries\fontsize{22pt}{25pt}\selectfont}{\par } \newenvironment{msHead}{\vskip 6pt}{\par} \newenvironment{msItem}{\vskip 6pt}{\par} \newenvironment{rubric}{}{} \newenvironment{titlePart}{}{\par } \newcolumntype{L}[1]{){\raggedright\arraybackslash}p{#1}} \newcolumntype{C}[1]{){\centering\arraybackslash}p{#1}} \newcolumntype{R}[1]{){\raggedleft\arraybackslash}p{#1}} \newcolumntype{P}[1]{){\arraybackslash}p{#1}} \newcolumntype{B}[1]{){\arraybackslash}b{#1}} \newcolumntype{M}[1]{){\arraybackslash}m{#1}} \definecolor{label}{gray}{0.75} \def\unusedattribute#1{\sout{\textcolor{label}{#1}}} \DeclareRobustCommand*{\xref}{\hyper@normalise\xref@} \def\xref@#1#2{\hyper@linkurl{#2}{#1}} \begingroup \catcode`\_=\active \gdef_#1{\ensuremath{\sb{\mathrm{#1}}}} \endgroup \mathcode`\_=\string"8000 \catcode`\_=12\relax \usepackage[a4paper,twoside,lmargin=1in,rmargin=1in,tmargin=1in,bmargin=1in,marginparwidth=0.75in]{geometry} \usepackage{framed} \definecolor{shadecolor}{gray}{0.95} \usepackage{longtable} \usepackage[normalem]{ulem} \usepackage{fancyvrb} \usepackage{fancyhdr} \usepackage{graphicx} \usepackage{marginnote} \renewcommand{\@cite}[1]{#1} \renewcommand*{\marginfont}{\itshape\footnotesize} \def\Gin@extensions{.pdf,.png,.jpg,.mps,.tif} \pagestyle{fancy} \usepackage[pdftitle={HbA1c as a Predictor of Postoperative Infection in Type 2 Diabetic Patients after Coronary Artery Bypass Grafting}, pdfauthor={}]{hyperref} \hyperbaseurl{} \paperwidth210mm \paperheight297mm \def\@pnumwidth{1.55em} \def\@tocrmarg {2.55em} \def\@dotsep{4.5} \setcounter{tocdepth}{3} \clubpenalty=8000 \emergencystretch 3em \hbadness=4000 \hyphenpenalty=400 \pretolerance=750 \tolerance=2000 \vbadness=4000 \widowpenalty=10000 \renewcommand\section{\@startsection {section}{1}{\z@}% {-1.75ex \@plus -0.5ex \@minus -.2ex}% {0.5ex \@plus .2ex}% {\reset@font\Large\bfseries}} \renewcommand\subsection{\@startsection{subsection}{2}{\z@}% {-1.75ex\@plus -0.5ex \@minus- .2ex}% {0.5ex \@plus .2ex}% {\reset@font\Large}} \renewcommand\subsubsection{\@startsection{subsubsection}{3}{\z@}% {-1.5ex\@plus -0.35ex \@minus -.2ex}% {0.5ex \@plus .2ex}% {\reset@font\large}} \renewcommand\paragraph{\@startsection{paragraph}{4}{\z@}% {-1ex \@plus-0.35ex \@minus -0.2ex}% {0.5ex \@plus .2ex}% {\reset@font\normalsize}} \renewcommand\subparagraph{\@startsection{subparagraph}{5}{\parindent}% {1.5ex \@plus1ex \@minus .2ex}% {-1em}% {\reset@font\normalsize\bfseries}} \def\l@section#1#2{\addpenalty{\@secpenalty} \addvspace{1.0em plus 1pt} \@tempdima 1.5em \begingroup \parindent \z@ \rightskip \@pnumwidth \parfillskip -\@pnumwidth \bfseries \leavevmode #1\hfil \hbox to\@pnumwidth{\hss #2}\par \endgroup} \def\l@subsection{\@dottedtocline{2}{1.5em}{2.3em}} \def\l@subsubsection{\@dottedtocline{3}{3.8em}{3.2em}} \def\l@paragraph{\@dottedtocline{4}{7.0em}{4.1em}} \def\l@subparagraph{\@dottedtocline{5}{10em}{5em}} \@ifundefined{c@section}{\newcounter{section}}{} \@ifundefined{c@chapter}{\newcounter{chapter}}{} \newif\if@mainmatter \@mainmattertrue \def\chaptername{Chapter} \def\frontmatter{% \pagenumbering{roman} \def\thechapter{\@roman\c@chapter} \def\theHchapter{\roman{chapter}} \def\thesection{\@roman\c@section} \def\theHsection{\roman{section}} \def\@chapapp{}% } \def\mainmatter{% \cleardoublepage \def\thechapter{\@arabic\c@chapter} \setcounter{chapter}{0} \setcounter{section}{0} \pagenumbering{arabic} \setcounter{secnumdepth}{6} \def\@chapapp{\chaptername}% \def\theHchapter{\arabic{chapter}} \def\thesection{\@arabic\c@section} \def\theHsection{\arabic{section}} } \def\backmatter{% \cleardoublepage \setcounter{chapter}{0} \setcounter{section}{0} \setcounter{secnumdepth}{2} \def\@chapapp{\appendixname}% \def\thechapter{\@Alph\c@chapter} \def\theHchapter{\Alph{chapter}} \appendix } \newenvironment{bibitemlist}[1]{% \list{\@biblabel{\@arabic\c@enumiv}}% {\settowidth\labelwidth{\@biblabel{#1}}% \leftmargin\labelwidth \advance\leftmargin\labelsep \@openbib@code \usecounter{enumiv}% \let\p@enumiv\@empty \renewcommand\theenumiv{\@arabic\c@enumiv}% }% \sloppy \clubpenalty4000 \@clubpenalty \clubpenalty \widowpenalty4000% \sfcode`\.\@m}% {\def\@noitemerr {\@latex@warning{Empty `bibitemlist' environment}}% \endlist} \def\tableofcontents{\section*{\contentsname}\@starttoc{toc}} \parskip0pt \parindent1em \def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}} \newenvironment{reflist}{% \begin{raggedright}\begin{list}{} {% \setlength{\topsep}{0pt}% \setlength{\rightmargin}{0.25in}% \setlength{\itemsep}{0pt}% \setlength{\itemindent}{0pt}% \setlength{\parskip}{0pt}% \setlength{\parsep}{2pt}% \def\makelabel##1{\itshape ##1}}% } {\end{list}\end{raggedright}} \newenvironment{sansreflist}{% \begin{raggedright}\begin{list}{} {% \setlength{\topsep}{0pt}% \setlength{\rightmargin}{0.25in}% \setlength{\itemindent}{0pt}% \setlength{\parskip}{0pt}% \setlength{\itemsep}{0pt}% \setlength{\parsep}{2pt}% \def\makelabel##1{\upshape ##1}}% } {\end{list}\end{raggedright}} \newenvironment{specHead}[2]% {\vspace{20pt}\hrule\vspace{10pt}% \phantomsection\label{#1}\markright{#2}% \pdfbookmark[2]{#2}{#1}% \hspace{-0.75in}{\bfseries\fontsize{16pt}{18pt}\selectfont#2}% }{} \def\TheFullDate{2020 2020-01-15 (revised: 24 Year 2020 15 January 2020)} \def\TheID{\makeatother } \def\TheDate{2020 2020-01-15} \title{HbA1c as a Predictor of Postoperative Infection in Type 2 Diabetic Patients after Coronary Artery Bypass Grafting} \author{}\makeatletter \makeatletter \newcommand*{\cleartoleftpage}{% \clearpage \if@twoside \ifodd\c@page \hbox{}\newpage \if@twocolumn \hbox{}\newpage \fi \fi \fi } \makeatother \makeatletter \thispagestyle{empty} \markright{\@title}\markboth{\@title}{\@author} \renewcommand\small{\@setfontsize\small{9pt}{11pt}\abovedisplayskip 8.5\p@ plus3\p@ minus4\p@ \belowdisplayskip \abovedisplayskip \abovedisplayshortskip \z@ plus2\p@ \belowdisplayshortskip 4\p@ plus2\p@ minus2\p@ \def\@listi{\leftmargin\leftmargini \topsep 2\p@ plus1\p@ minus1\p@ \parsep 2\p@ plus\p@ minus\p@ \itemsep 1pt} } \makeatother \fvset{frame=single,numberblanklines=false,xleftmargin=5mm,xrightmargin=5mm} \fancyhf{} \setlength{\headheight}{14pt} \fancyhead[LE]{\bfseries\leftmark} \fancyhead[RO]{\bfseries\rightmark} \fancyfoot[RO]{} \fancyfoot[CO]{\thepage} \fancyfoot[LO]{\TheID} \fancyfoot[LE]{} \fancyfoot[CE]{\thepage} \fancyfoot[RE]{\TheID} \hypersetup{citebordercolor=0.75 0.75 0.75,linkbordercolor=0.75 0.75 0.75,urlbordercolor=0.75 0.75 0.75,bookmarksnumbered=true} \fancypagestyle{plain}{\fancyhead{}\renewcommand{\headrulewidth}{0pt}} \date{} \usepackage{authblk} \providecommand{\keywords}[1] { \footnotesize \textbf{\textit{Index terms---}} #1 } \usepackage{graphicx,xcolor} \definecolor{GJBlue}{HTML}{273B81} \definecolor{GJLightBlue}{HTML}{0A9DD9} \definecolor{GJMediumGrey}{HTML}{6D6E70} \definecolor{GJLightGrey}{HTML}{929497} \renewenvironment{abstract}{% \setlength{\parindent}{0pt}\raggedright \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}} \vskip16pt \textcolor{GJBlue}{\large\bfseries\abstractname\space} }{% \vskip8pt \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}} \vskip16pt } \usepackage[absolute,overlay]{textpos} \makeatother \usepackage{lineno} \linenumbers \begin{document} \author[1]{Patricia Veloso Facury Lasmar Ferreira} \author[2]{Wagner José Martorina} \author[3]{Bruno Bastos Godoi} \affil[1]{ BIOCOR Institute} \renewcommand\Authands{ and } \date{\small \em Received: 8 December 2019 Accepted: 2 January 2020 Published: 15 January 2020} \maketitle \begin{abstract} Coronary artery disease (CAD) is one of the leading causes of morbimortality worldwide. In patients with diabetes mellitus type 2 (DM2), CAD is more likely to be a complex disease and often requires cardiac surgery. Furthermore, perioperative blood glucose levels control is associated with the followingoutcomes: surgery success, mortality, and infection postoperative. This is a retrospective study, we have collected data form, 43 patients, between 2015 and 2017, with diabetes type 2 and who had passed through a Coronary Artery Bypass Grafting. Those with infection postoperative had a glycohemoglobin 7, 9 (SD ±1,4), and those without infection had an HbA1c 7, 25 (SD ±0,94) and a p-value from 0,039. Adding this was identified that the average of creatinine clearance in patients with the infectious disease was 59 (SD ±21, 3) and 67 (SD ±26) in those without infection, calculated a p-value from 0,039. High levels of Hb1Ac are a predictor of infection disease postoperative. \end{abstract} \keywords{diabetes mellitus;coronary disease; cardiovascular surgical procedures; cross infection; glycated hemoglobin A.} \begin{textblock*}{18cm}(1cm,1cm) % {block width} (coords) \textcolor{GJBlue}{\LARGE Global Journals \LaTeX\ JournalKaleidoscope\texttrademark} \end{textblock*} \begin{textblock*}{18cm}(1.4cm,1.5cm) % {block width} (coords) \textcolor{GJBlue}{\footnotesize \\ Artificial Intelligence formulated this projection for compatibility purposes from the original article published at Global Journals. However, this technology is currently in beta. \emph{Therefore, kindly ignore odd layouts, missed formulae, text, tables, or figures.}} \end{textblock*} \let\tabcellsep& \section[{Introduction}]{Introduction}\par ne of the leading causes of morbimortality worldwide is coronary artery disease (CAD), which has many risk factors in the pathophysiology of the issue, which is why the forerunning risk factor is diabetes mellitus type 2(DM2) 1 .In patients with DM2, CAD is more likely to be a complex disease characterized by small, diffuse, calcified, multivessel disease and often requires coronary revascularization \hyperref[b1]{2,}\hyperref[b2]{3} .\par Many clinical trials \hyperref[b0]{1,}\hyperref[b1]{2,}\hyperref[b3]{[4]}\hyperref[b4]{[5]}\hyperref[b5]{[6]}\hyperref[b6]{[7]}\hyperref[b7]{[8]} have demonstrated that postoperative myocardial infectious complications in patients with DM2 are associated with the following conditions: blood glucose control, length of stay in the hospital, or in the intensive unit care (ICU), renal failure and previous lung disease \hyperref[b7]{8,}\hyperref[b8]{9} .\par The current study evaluates which variables are associated with a significant risk of hospital infection of any nature in patients with DM2. The central hypothesis is that preoperative blood glucose level, and HbA1c on in-hospital outcomes, principally associated with infections after CABG. \section[{II.}]{II.} \section[{Methodology}]{Methodology}\par This is a transversal study; we have collected data between 2015 and 2017 from all patients with type 2 diabetes who passed through a Coronary Artery Bypass Grafting. During this period, CABG performed in 43 patients with DM2. This number has reached because of inclusion criteria: 1) patients who would pass through a cardiac surgery, 2) patients diagnosed with DM2, 3) patients under the care of endocrinology staff. And the exclusion criteria were faulting data at the medical records of those patients. Moreover, were collected the following records: gender, age, HbA1c level, time diabetic diagnosed, insulin user (yes or not), time-elapsed in hospital and the ICU, smoking history, pulmonary disease, and infection postoperative. The Ethical Committee in Research approved this study by the BIOCOR hospital. \section[{III.}]{III.} \section[{Statistical Analysis}]{Statistical Analysis}\par The chi-square test used in categorical variables (for example, presence or absence of lung disease, use of insulin or not, etc.), with the p-value calculated by the person's square. In the univariate analysis, the continuous numerical variables, when in the standard distribution in the course of Gauss, were analyzed by the T-test of independent samples. And, when not parametric, they were analyzed by the Mann Whitney U test.\par IV. \section[{Results}]{Results}\par Were collected data from 43 patients with DM2 that passed through a CABG for myocardial revascularization. The average age was 65, an average of 8 years diagnosed with DM2 (standard deviation of 8,8), and from all, only 34,8\% used insulin to treat and normalize glucose levels (Table \hyperref[tab_0]{1}).\par Moreover, were identified an average of glycohemoglobin of 7, 4. Furthermore, 14, 6\% of the patients had some type of infectious disease after CABG. Those with infection postoperative had a glycohemoglobin 7, 9 (SD ±1,4), and those without infection had an HbA1c 7,25 (SD ±0,94) and a p-value from 0,039 (graphic1).Adding this was identified that the average of creatinine clearance in those patients with the infectious disease was 59 (SD ±21,3) and 67 (SD ±26) in those without infection, calculated a p-value from 0,039 (table 2). V. \section[{Discussion}]{Discussion}\par This study has shown that high levels of Hb1Ac and low levels of creatinine clearance are a predictor of infection disease post CADG.\par Izadi, et al. (2014) \hyperref[b18]{19} have demonstrated that immunosuppression induced by hyperglycemiaketoacidosis can be considered as the precedent factor in patients with DM2 to infection, principally after CADG \hyperref[b0]{1,}\hyperref[b4]{5,}\hyperref[b12]{13,}\hyperref[b17]{18,}\hyperref[b18]{19} . Comparatively, our study showed high levels of infection disease postoperative in patients with previous uncontrolled Hb1AC.\par It is controversial what glycemic parameter used as a predictor of postoperative infection disease after CABG. Some authors defend tight blood glucose control as a decreasing factor of morbidity, mortality, and lower rates of infection after cardiac surgeries, principally associated with blood glucose < 200 mg/dL, and <139mg/dL if in ICU. Others defend a more straight target of blood glucose (81 to 108 mg/dL) \hyperref[b0]{1,}\hyperref[b6]{7,}\hyperref[b8]{9,}\hyperref[b11]{12,}\hyperref[b23]{24} . Other researchers advocate that patients with HbA1c lower than 7\% have a better outcome than patients with poorly controlled diabetes (HbA1c> 7\%) \hyperref[b12]{13} , which also demonstrated with our results that those patients with infectious disease had an HbA1c> 7,9.\par Also, patients with HbA1c lower than 7\% had similar outcomes compared to those without diabetes diagnosis \hyperref[b15]{16,}\hyperref[b17]{18,}\hyperref[b24]{25} . This can corroborate with Halkos et al. (2008) \hyperref[b15]{16} , demonstrating a significant increase in in-hospital mortality, renal failure, cerebrovascular accident, deep sternal wound infection, and a composite index of infection in those patients with HbA1c levels higher than 7\%. So then, preoperative glycosylated hemoglobin emerges as a predictor of mortality and principally infections postoperative after CABG \hyperref[b15]{16} .\par Another variable as a predictor of postoperative infection is the creatinine clearance (CrCl). As shown by Kassaianet al. (2012) \hyperref[b17]{18} and Halkos et al. (2008) \hyperref[b15]{16} , CrCl, as HbA1c levels, predict infection disease postoperative 7,8,12,26,27 . We have also shown similar results. In all patients with infection after CAGD, the CrCl was lower than 59, with a p-value of 0,039.\par There are potential limitations in our study that needs to mention. First, it designs retrospective research. Second, this was a single-center experience, and larger multi-center studies should confirm our findings. Third, multivariable analysis was not made, so independent associations cannot be summarized from this study. \section[{VI.}]{VI.} \section[{Conclusion}]{Conclusion}\par In summary, high levels of Hb1Ac are a predictor of infection disease post CADG. Thereby, patients with coronaropathy must be the glucose levels, and mainly HbA1c levels, evaluated before cardiac surgery. Moreover, creatinine clearance should also be evaluated to predict poor outcomes postoperative in patients with DM2.\par These findings demonstrate that it is quite essential a holistic medical evaluation in patients with DM2 before cardiac surgeries, focusing on the glucose levels control, HbA1c, and renal function to obtain a lower risk of postoperative infectious complications.\par Further researches must be developed to evaluate, prospectively, with a biggersample, a significant association between HbA1c and postoperative infection in patients with DM2 submitted through a CABG.\begin{figure}[htbp] \noindent\textbf{1} \par \begin{longtable}{P{0.5509955752212389\textwidth}P{0.29900442477876105\textwidth}} Variables\tabcellsep N (\%) or median (Quartile 25-75\%) or average (SD)\\ Age (years)\tabcellsep 65 (± 9,3)\\ Female\tabcellsep 17 (39,6\%)\\ Glycohemoglobin (\%)\tabcellsep 7,40 (±1,08)\\ Length of DM2 (years)\tabcellsep 8 (±8,8)\\ Length of hospital stay until surgery(days)\tabcellsep 5 (±8,8)\\ Drain time in UCI (days)\tabcellsep 1\\ Length of stay in UCI (days)\tabcellsep 2 (±1,5)\\ Creatinine clearance (mL/min)\tabcellsep 67 (±25,5)\\ Presence of infectious disease after CABG\tabcellsep 8 (14,6\%)\\ Use of insulin before hospitalization\tabcellsep 15 (34,8\%)\\ Smoking\tabcellsep 3 (7,3\%)\\ Pulmonary disease\tabcellsep 8 (19,5\%)\end{longtable} \par \caption{\label{tab_0}Table 1 :}\end{figure} \begin{figure}[htbp] \noindent\textbf{2} \par \begin{longtable}{P{0.3881076388888889\textwidth}P{0.19184027777777776\textwidth}P{0.1859375\textwidth}P{0.08411458333333333\textwidth}} Variables\tabcellsep Absence of infectious\tabcellsep Presence of infectious\tabcellsep p-value\\ \tabcellsep disease\tabcellsep disease\tabcellsep \\ Average age (years)\tabcellsep 65 (± 9,32)\tabcellsep 65 (± 8,9)\tabcellsep 0,059\\ Female\tabcellsep 15 (34,8\%)\tabcellsep 2 (4,6\%)\tabcellsep 0,51\\ Glycohemoglobin (\%)\tabcellsep 7,25 (±0,94)\tabcellsep 7,9 (±1,4)\tabcellsep 0,039\\ Length of DM2 (years)\tabcellsep 8 (±8,98)\tabcellsep 10 (±9)\tabcellsep 0,057\\ Length of hospital stay until surgery (days)\tabcellsep 6,7 (1,5-8)\tabcellsep 12,8 (4 -25)\tabcellsep 0,223\\ Drain time in UCI (days)\tabcellsep 1\tabcellsep 1\tabcellsep 1\\ Length of stay in UCI (days)\tabcellsep 2 (±1,5)\tabcellsep 2 (±1,7)\tabcellsep 0,062\\ Creatinine clearance (mL/min)\tabcellsep 67 (±26)\tabcellsep 59 (±21,3)\tabcellsep 0,039\\ Use of insulin prior to hospitalization\tabcellsep 11 (30,6\%)\tabcellsep 4 (57,1\%)\tabcellsep 0,177\\ Smoking\tabcellsep 2 (5,7\%)\tabcellsep 1 (16,7\%)\tabcellsep 0,341\\ Pulmonary disease\tabcellsep 28 (82,9\%)\tabcellsep 5 (71,4\%)\tabcellsep 0,482\end{longtable} \par \caption{\label{tab_1}Table 2 :}\end{figure} \backmatter \begin{bibitemlist}{1} \bibitem[Anesth ()]{b25}\label{b25} \textit{}, Anesth . 2013. 27 p. . \bibitem[Lee et al. ()]{b7}\label{b7} \textit{A study of a preoperative intervention in patients with diabetes undergoing cardiac surgery}, G A Lee , S Wyatt , D Topliss , K Z Walker , R Stoney . 2014. 21 p. . \bibitem[Kim ()]{b27}\label{b27} ‘Analysis of multiple risk factors affecting the result of free flap transfer for necrotising soft tissue defects of the lower extremities in patients with type 2 diabetes mellitus’. B K Kim . \textit{J. Plast. Reconstr. Aesthetic Surg} 2014. 67 p. . \bibitem[Aronson and Edelman ()]{b9}\label{b9} ‘Coronary artery disease and diabetes mellitus’. D Aronson , E R Edelman . \textit{Cardiol} 2014. 32 p. . \bibitem[Naito and Miyauchi ()]{b1}\label{b1} ‘Coronary Artery Disease, and Type 2 Diabetes Mellitus. Int’. R Naito , K Miyauchi . \textit{Heart J} 2017. 58 p. . \bibitem[Vannini ()]{b3}\label{b3} ‘Diabetes as pro-infective risk factor in total HIP replacement’. P Vannini . \textit{Acta Diabetol. Lat} 1984. 21 p. . \bibitem[Carson ()]{b19}\label{b19} ‘Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery’. J L Carson . \textit{J. Am. Coll. Cardiol} 2002. 40 p. . \bibitem[Strahan ()]{b20}\label{b20} ‘Diabetic control and coronary artery bypass: Effect on short-term outcomes’. S Strahan . \textit{Asian Cardiovasc. Thorac. Ann} 2013. 21 p. . \bibitem[Rawlins et al. ()]{b13}\label{b13} ‘Effect of elevated hemoglobin A1c in diabetic patients on complication rates after Roux-en-Y gastric bypass’. L Rawlins , M P Rawlins , C C Brown , D L Schumacher . \textit{Surg. Obes. Relat. Dis} 2013. 9 p. . \bibitem[Halkos ()]{b15}\label{b15} ‘Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery’. M E Halkos . \textit{J. Thorac. Cardiovasc. Surg} 2008. 136 p. . \bibitem[Grocott ()]{b6}\label{b6} ‘Glucose and outcome after cardiac surgery: What are the issues?’. H P Grocott . \textit{J. Extra. Corpor. Technol} 2006. 38 p. . \bibitem[Zerr ()]{b16}\label{b16} ‘Glucose Control Lowers the Risk of Wound Infection in Diabetics after Open Heart Operations’. Mba Zerr , KJ . \textit{Ann. Thorac. Surg} 2002. 63 p. . \bibitem[Izadi ()]{b18}\label{b18} ‘Glycemic control in type 2 diabetes mellitus prevents coronary arterial wall infection’. M Izadi . \textit{ARYA Atheroscler} 2014. 10 p. . \bibitem[Wallia ()]{b0}\label{b0} ‘Glycemic control reduce infections in post-liver transplant patients: Results of a prospective, randomized study’. A Wallia . \textit{J. Clin. Endocrinol. Metab} 2017. 102 p. . \bibitem[Kassaian ()]{b17}\label{b17} ‘Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting’. S E Kassaian . \textit{Cardiovasc. Diabetol} 2012. 11 p. 1. \bibitem[Masla et al. ()]{b12}\label{b12} ‘HbA1c and diabetes predict perioperative hyperglycemia and glycemic variability in on-pump coronary artery bypass graft patients’. M Masla , A Gottschalk , M E Durieux , D S Groves . \textit{J. Cardiothorac. Vasc. Anesth} 2011. 25 p. . \bibitem[Hamilton ()]{b21}\label{b21} ‘Incidence and Predictors of Hospitalization for Bacterial Infection in Community-Based Patients with Type 2 Diabetes: The Fremantle Diabetes Study’. E J Hamilton . \textit{PLoS} 2013. 8 p. . \bibitem[Morris ()]{b4}\label{b4} \textit{Influence of Diabetes Mellitus on Early and Late Outcome after Percutaneous Transluminal Coronary Angioplasty}, D C Morris . 2012. 91 p. . \bibitem[Al-Niaimi ()]{b23}\label{b23} ‘Intensive postoperative glucose control reduces the surgical site infection rates in gynecologic oncology patients’. A N Al-Niaimi . \textit{Gynecol. Oncol} 2015. 136 p. . \bibitem[Rutering ()]{b2}\label{b2} ‘Pathology of Human Coronary and Carotid Artery Atherosclerosis and Vascular Calcification in Diabetes’. J Rutering . \textit{Nat. Rev Drug Discov} 2016. 5 p. . \bibitem[Lee et al. ()]{b11}\label{b11} ‘Perioperative Glucose Control and Infection Risk in Older Surgical Patients’. P Lee , L Min , L Mody . \textit{Curr. Geriatr} 2014. 3 p. . \bibitem[Guvener et al. ()]{b5}\label{b5} ‘Perioperative Hyperglycemia Is a Strong Correlate of Postoperative Infection in Type II Diabetic Patients after Coronary Artery Bypass Grafting’. M Guvener , I Pasaoglu , M Demircin , M Oc . \textit{Endocrine} 2003. 49 p. . \bibitem[Breithaupt ()]{b8}\label{b8} ‘Postoperative Glycemic Control in Cardiac Surgery Patients’. T Breithaupt . \textit{Baylor Univ. Med. Cent. Proc} 2017. 23 p. . \bibitem[Santos et al. ()]{b10}\label{b10} ‘Prognosis and Complications of Diabetic Patients Undergoing Isolated Coronary Artery Bypass Surgery’. K A Q Santos , B Berto , A G Sousa , F A A Costa , Da . \textit{Brazilian J. Cardiovasc. Surg} 2016. 31 p. . \bibitem[Gottschalk ()]{b22}\label{b22} ‘Staphylococcus aureus Infections in German Patients with Type 2 Diabetes Mellitus after Orthopedic Surgery: Incidence, Risk Factors, and Clinical and Health-Economic Outcomes’. F Gottschalk . \textit{Surg. Infect. (Larchmt)} 2017. 18 p. . \bibitem[Sato ()]{b26}\label{b26} ‘The association of preoperative glycemic control, intraoperative insulin sensitivity, and outcomes after cardiac surgery’. H Sato . \textit{J. Clin. Endocrinol. Metab} 2010. 95 p. . \bibitem[Woods et al. ()]{b14}\label{b14} \textit{The influence of type 2 diabetes mellitus in patients undergoing coronary artery bypass graft surgery: An 8-year prospective cohort study}, S E Woods , J M Smith , S Sohail , A Sarah , A Engle . 2004. 126 p. . \bibitem[Gumus]{b24}\label{b24} ‘Use of a lower cut-off value for HbA1c to predict postoperative renal complication risk in patients undergoing coronary artery bypass grafting’. F Gumus . \textit{J. Cardiothorac. Vasc} \end{bibitemlist} \end{document}